PMID- 29700574 OWN - NLM STAT- MEDLINE DCOM- 20190102 LR - 20190102 IS - 1615-2573 (Electronic) IS - 0910-8327 (Linking) VI - 33 IP - 11 DP - 2018 Nov TI - Serum brain-derived neurotrophic factor level and exercise tolerance complement each other in predicting the prognosis of patients with heart failure. PG - 1325-1333 LID - 10.1007/s00380-018-1174-9 [doi] AB - Brain-derived neurotropic factor (BDNF) is a myokine that plays a key role in regulating survival, growth, and maintenance of neurons. We investigated whether the serum BDNF level at discharge could predict the prognosis in patients with heart failure (HF). Furthermore, we aimed to examine the relationship between this myokine and exercise tolerance. We prospectively enrolled 94 patients who were hospitalized for worsening HF and had cardiac rehabilitation. At discharge, the serum BDNF level of all patients was measured using a commercial ELISA kit and they underwent a cardiopulmonary exercise test to measure peak oxygen uptake (peak VO(2)). Correlation was not observed between BDNF and peak VO(2). Kaplan-Meier analysis demonstrated that cardiac death or rehospitalization owing to worsening HF was significantly higher in the low BDNF group (p = 0.023). The combination of peak VO(2) and BDNF levels led to the identification of subgroups with significantly different probabilities of events (p = 0.005). In particular, in the low BDNF and low peak VO(2) group, the frequency of rehospitalization within half a year after discharge was much higher than that in other groups. Multivariate analysis found BDNF as an independent factor of adverse events (hazard ratio 0.956; 95% confidence interval 0.911-0.999; p = 0.046). The serum BDNF level at discharge may be a useful biomarker of the prognosis in patients with HF. Furthermore, combining BDNF and peak VO(2) may be useful for predicting early cardiac events. FAU - Shibata, Atsushi AU - Shibata A AD - Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. FAU - Hanatani, Akihisa AU - Hanatani A AUID- ORCID: 0000-0003-1014-7447 AD - Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. hanatania@msic.med.osaka-cu.ac.jp. FAU - Izumi, Yasukatsu AU - Izumi Y AD - Department of Internal Medicine, Takaishikamo Hospital, Osaka, Japan. FAU - Kitada, Ryoko AU - Kitada R AD - Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. FAU - Iwata, Shinichi AU - Iwata S AD - Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. FAU - Yoshiyama, Minoru AU - Yoshiyama M AD - Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. LA - eng PT - Journal Article DEP - 20180426 PL - Japan TA - Heart Vessels JT - Heart and vessels JID - 8511258 RN - 0 (Biomarkers) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Aged MH - Biomarkers/blood MH - Brain-Derived Neurotrophic Factor/*blood MH - Exercise Tolerance/*physiology MH - Female MH - Follow-Up Studies MH - Heart Failure/blood/mortality/*physiopathology MH - Humans MH - Japan/epidemiology MH - Male MH - Middle Aged MH - Oxygen Consumption/*physiology MH - Prognosis MH - Prospective Studies MH - Stroke Volume/*physiology MH - Survival Rate/trends OTO - NOTNLM OT - Brain-derived neurotropic factor OT - Exercise tolerance OT - Heart failure OT - Myokines OT - Prognosis EDAT- 2018/04/28 06:00 MHDA- 2019/01/03 06:00 CRDT- 2018/04/28 06:00 PHST- 2018/01/29 00:00 [received] PHST- 2018/04/20 00:00 [accepted] PHST- 2018/04/28 06:00 [pubmed] PHST- 2019/01/03 06:00 [medline] PHST- 2018/04/28 06:00 [entrez] AID - 10.1007/s00380-018-1174-9 [pii] AID - 10.1007/s00380-018-1174-9 [doi] PST - ppublish SO - Heart Vessels. 2018 Nov;33(11):1325-1333. doi: 10.1007/s00380-018-1174-9. Epub 2018 Apr 26.